Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -84K -42.20% | 115,600 0.14% of shares | low |
| Mar 20, 2026 | Esposito Pamela Director | Exercise | Stock Option (Right to Buy) | — | -3K -100.00% | 0 0.00% of shares | low |
| Mar 11, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -20K -24.83% | 60,548 0.07% of shares | low |
| Mar 2, 2026 | Adams Brian Executive | Grant | Stock Option (Right to Buy) | — | +8K | 8,250 <0.01% of shares | low |
| Mar 2, 2026 | Chadwick Jeremy G Executive | Grant | Stock Option (Right to Buy) | — | +25K | 25,150 0.03% of shares | low |
| Mar 2, 2026 | Goodman Noah Executive | Grant | Stock Option (Right to Buy) | — | +18K | 18,450 0.02% of shares | low |
| Feb 20, 2026 | Esposito Pamela Director | Exercise | Stock Option (Right to Buy) | — | -3K -50.00% | 2,500 <0.01% of shares | low |
| Jan 20, 2026 | Esposito Pamela Director | Exercise | Stock Option (Right to Buy) | — | -3K -33.33% | 5,000 <0.01% of shares | low |
| Jan 20, 2026 | Esposito Pamela Director | Exercise | Stock Option (Right to Buy) | — | -3K -23.08% | 10,000 0.01% of shares | low |